Development issues: antibody stability, developability, immunogenicity, and comparability - ScienceDirect
Sequence Liability Identification - Creative Biolabs
Introducing New Antibody Property Prediction Tools
Five computational developability guidelines for therapeutic antibody profiling | PNAS
Specialized Antibody Characterization - Curia Global
Observed Antibody Space + miAIRR | Oxford Protein Informatics Group
Annotate antibody specific information on protein sequences – Benchling
Antibodies | Free Full-Text | Antibody Aggregation: Insights from Sequence and Structure
Accurate detection of liabilities to de-risk antibody development
Utilizing cross-product prior knowledge to rapidly de-risk chemical liabilities in therapeutic antibody candidates | AAPS Open | Full Text
Frequency of liability motifs in all CDRs. Circles show percentages of... | Download Scientific Diagram
Computational antibody methods schematic. (A) Antibody modelling... | Download Scientific Diagram
Orion Antibody Discovery Suite - AbXtract
Accurate detection of liabilities to de-risk antibody development
Frontiers | Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies | SpringerLink
Align and Prioritize your Antibody Sequences
Developability Predictions for Antibody Engineering and Risk Mitigation | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Harnessing the rabbit antibody repertoire - Fusion Antibodies
Samuel Schmitz – Vanderbilt Program for Next Generation Vaccines – Integrating Structural Biology with Big Data
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries
Development issues: antibody stability, developability, immunogenicity, and comparability - ScienceDirect
How to Customize Sequence Liabilities and Assets – Geneious Biologics Support
